Organ dysfunction, injury, and failure in cardiogenic shock

Abstract Background Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). Main body Although a low cardiac index is a common finding in...

Full description

Bibliographic Details
Main Authors: Akihiro Shirakabe, Masato Matsushita, Yusaku Shibata, Shota Shighihara, Suguru Nishigoori, Tomofumi Sawatani, Kazutaka Kiuchi, Kuniya Asai
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Journal of Intensive Care
Subjects:
Online Access:https://doi.org/10.1186/s40560-023-00676-1
_version_ 1797789949950427136
author Akihiro Shirakabe
Masato Matsushita
Yusaku Shibata
Shota Shighihara
Suguru Nishigoori
Tomofumi Sawatani
Kazutaka Kiuchi
Kuniya Asai
author_facet Akihiro Shirakabe
Masato Matsushita
Yusaku Shibata
Shota Shighihara
Suguru Nishigoori
Tomofumi Sawatani
Kazutaka Kiuchi
Kuniya Asai
author_sort Akihiro Shirakabe
collection DOAJ
description Abstract Background Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). Main body Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (“forward failure”) to venous congestion (“backward failure”) as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure. Conclusions Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS.
first_indexed 2024-03-13T01:57:56Z
format Article
id doaj.art-fbfaefd6f7a846fa8d7e350371fc6926
institution Directory Open Access Journal
issn 2052-0492
language English
last_indexed 2024-03-13T01:57:56Z
publishDate 2023-06-01
publisher BMC
record_format Article
series Journal of Intensive Care
spelling doaj.art-fbfaefd6f7a846fa8d7e350371fc69262023-07-02T11:09:03ZengBMCJournal of Intensive Care2052-04922023-06-011111910.1186/s40560-023-00676-1Organ dysfunction, injury, and failure in cardiogenic shockAkihiro Shirakabe0Masato Matsushita1Yusaku Shibata2Shota Shighihara3Suguru Nishigoori4Tomofumi Sawatani5Kazutaka Kiuchi6Kuniya Asai7Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDivision of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDivision of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDivision of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDivision of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDivision of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDivision of Intensive Care Unit, Nippon Medical School Chiba Hokusoh HospitalDepartment of Cardiovascular Medicine, Nippon Medical SchoolAbstract Background Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). Main body Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (“forward failure”) to venous congestion (“backward failure”) as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure. Conclusions Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS.https://doi.org/10.1186/s40560-023-00676-1Acute decompensated heart failureBiomarkerMortalityInflammation
spellingShingle Akihiro Shirakabe
Masato Matsushita
Yusaku Shibata
Shota Shighihara
Suguru Nishigoori
Tomofumi Sawatani
Kazutaka Kiuchi
Kuniya Asai
Organ dysfunction, injury, and failure in cardiogenic shock
Journal of Intensive Care
Acute decompensated heart failure
Biomarker
Mortality
Inflammation
title Organ dysfunction, injury, and failure in cardiogenic shock
title_full Organ dysfunction, injury, and failure in cardiogenic shock
title_fullStr Organ dysfunction, injury, and failure in cardiogenic shock
title_full_unstemmed Organ dysfunction, injury, and failure in cardiogenic shock
title_short Organ dysfunction, injury, and failure in cardiogenic shock
title_sort organ dysfunction injury and failure in cardiogenic shock
topic Acute decompensated heart failure
Biomarker
Mortality
Inflammation
url https://doi.org/10.1186/s40560-023-00676-1
work_keys_str_mv AT akihiroshirakabe organdysfunctioninjuryandfailureincardiogenicshock
AT masatomatsushita organdysfunctioninjuryandfailureincardiogenicshock
AT yusakushibata organdysfunctioninjuryandfailureincardiogenicshock
AT shotashighihara organdysfunctioninjuryandfailureincardiogenicshock
AT sugurunishigoori organdysfunctioninjuryandfailureincardiogenicshock
AT tomofumisawatani organdysfunctioninjuryandfailureincardiogenicshock
AT kazutakakiuchi organdysfunctioninjuryandfailureincardiogenicshock
AT kuniyaasai organdysfunctioninjuryandfailureincardiogenicshock